{"transactions":[{"id":1276951,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-11T02:30:11.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":63604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in two equal installments on the 90th and 180th day following the date of the grant, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of (i) 205,784 shares of common stock and (ii) 63,604 unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities reported herein reflects the effects of a 1-for-10 reverse stock split effected by the Issuer on July 17, 2024, which was exempt from reporting pursuant to Rule 16a-9."}],"balance_after":269388,"source":{"system":"sec-edgar","filing":"0001493152-25-005766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225005766/ownership.xml","form_type":"4"}},{"id":1798875,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-24T01:39:23.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of (i) 254,505 vested stock options and (ii) 2,759,914 stock options that will vest in eleven equal quarterly installments from October 14, 2023 to April 14, 2026. The options become exercisable upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Consists of (i) 254,505 vested stock options and (ii) 2,759,914 stock options that will vest in eleven equal quarterly installments from October 14, 2023 to April 14, 2026. The options become exercisable upon vesting."}],"balance_after":3014419,"derivative":{"exercise_price":0.419,"expiration_date":"2032-10-26","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-23-030021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223030021/ownership.xml","form_type":"4"}},{"id":1798874,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-24T01:39:23.000Z","date":"2023-08-23","kind":"exercise","planned":false,"acquired":true,"shares":1000000,"price":0.419,"value":419000.0,"ownership":{"direct":true},"balance_after":2057831,"source":{"system":"sec-edgar","filing":"0001493152-23-030021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315223030021/ownership.xml","form_type":"4"}},{"id":2108885,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right-to-Buy)","published_at":"2022-11-22T02:45:18.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":4014419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four-year period, with one quarter (1/4) of the options vesting on April 14, 2023 (the one-year anniversary of the date of the Reporting Person's appointment as CEO of Sonim Technologies, Inc.), and all remaining options vesting in equal quarterly installments in the amount of one-twelfth (1/12) of the remaining options amount thereafter."}],"balance_after":4014419,"derivative":{"exercise_price":0.419,"expiration_date":"2032-10-26","underlying":"Common Stock","underlying_shares":4014419},"source":{"system":"sec-edgar","filing":"0001493152-22-033223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222033223/ownership.xml","form_type":"4"}},{"id":2207594,"issuer":{"id":8261,"kind":"organization","name":"DNA X, Inc."},"owners":[{"id":83443,"kind":"person","name":"Liu Hao Peter","position":1,"cik":"0001925315","reported_name":"Liu Hao Peter","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-07-15T00:59:09.000Z","date":"2022-07-13","kind":"purchase","acquired":true,"shares":952381,"price":0.84,"value":800000.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares issued to the reporting person as a designee of AJP Holding Company, LLC in the first closing pursuant to the subscription agreement dated April 13, 2022 by and between the AJP Holding Company, LLC and Sonim Technologies, Inc."}],"balance_after":1059867,"source":{"system":"sec-edgar","filing":"0001493152-22-019364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315222019364/ownership.xml","form_type":"4"}}]}